Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T09:08:23.207Z Has data issue: false hasContentIssue false
  • English
  • Français

A Controlled Trial of Fluphenazine Enanthate in Hospitalized Chronic Schizophrenics

Published online by Cambridge University Press:  29 January 2018

Ijaz Haider
Ijaz Haider*
Affiliation:
22-L, Edinburgh University Department of Psychiatry, Royal Edinburgh Hospital, Morningside Park, Edinburgh 10; St. Francis Hospital and Hurstwood Park Hospital, Haywards Heath, Sussex
Get access Rights & Permissions [Opens in a new window]

Extract

The need for a long-acting phenothiazine has been long recognized, especially since it has been shown (Parkes et al., 1962; Renton et al., 1963; Kline, 1964; Willcox et al., 1965; Wilson and Enoch, 1967) that a high proportion of schizophrenic patients do not take their prescribed medicines.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 114 , Issue 512 , July 1968 , pp. 837 - 841
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barsa, J. A., and Saunders, J. C. (1965). “A double-blind study of fluphenazine enanthate” Dis. nerv. Syst., 26, 496–498.Google Scholar
Bartholomew, A. A., and Holt, N. F. (1966). “A long acting phenothiazine (fluphenazine enanthate): a preliminary communication” Med. J. Australia, 1, 12–17.Google Scholar
Bethell, M. S., et al. (1966). “Fluphenazine enanthate in the maintenance treatment of schizophrenia” Brit. med. J., ii, 1262.Google Scholar
Cochran, W. G., and Cox, G. M. (1960). Experimental Designs. 2nd ed. New York and London: L. Wiley and Sons.Google Scholar
Dillon, J. B., and Bates, T. J. N. (1966). “Fluphenazine enanthate in the maintenance treatment of schizophrenia” Brit. med. J., ii, 1328.CrossRefGoogle Scholar
Forrest, A. D. (1966). “Fluphenazine enanthate in the maintenance treatment of schizophrenia” Ibid., ii, 1263.Google Scholar
Hamilton, M., Smith, A. L. G., Lapidus, H. E., and Cadogan, E. P. (1960). “A controlled trial of thiopropazate dihydrochloride (Dartalan), chlorpromazine and occupational therapy in chronic schizophrenics” J. ment. Sci., 106, 40–55.Google Scholar
Howell, R. J., Brown, H. M., Beaghler, H. E. (1961). “A comparison of fluphenazine, trifluoperazine and a placebo in the context of an active treatment unit” J. nerv. ment. Dis., 132, 522–530.Google Scholar
Kinross-Wright, J., and Charalampous, K. D. (1965). “A controlled study of a very long-acting phenothiazine preparation” Int. J. Neuropsychiat., 1, 66–70.Google Scholar
Kline, N. S., and Simpson, G. M. (1964). “A long-acting phenothiazine in office practice” Amer. J. Psychiat., 120, 1012–1014.Google Scholar
Kurland, A. A., Gruenwald, F., Vega, L., and Wittig, B. A. (1964). “Fluphenazine (Proxilin) enanthate—a phenothiazine preparation of prolonged activity” Curr. ther. Res., 6, 137–147.Google Scholar
Lowther, J. (1967). “Side-effects of phenothiazines” Brit. J. Psychiat., 113, 557–558.Google Scholar
Millar, J. (1963). “A trial of fluphenazine in schizophrenia” Ibid., 109, 428–432.Google Scholar
The National Institute of Mental Health Psychopharmacology Service Center Collaborative Study Group (1964). “Phenothiazine treatment in acute schizophrenia” Arch. gen. Psychiat., 10, 246–261.Google Scholar
Parkes, C. M., Brown, G. W., and Monck, E. M. (1962). “The general practitioner and the schizophrenic patient” Brit. med. J., i, 972–976.Google Scholar
Ravaris, C. L., Weaver, L. A., Brooks, G. W. (1965). “A controlled study of fluphenazine enanthate in chronic schizophrenic patients” Dis. nerv. Syst., 26, 33–39.Google Scholar
Renton, C. A., Affleck, J. W., Carstairs, G. M., Forrest, A. D. (1963). “A follow-up of schizophrenic patients in Edinburgh” Acta psychiat. Scand., 39, 548–600.Google Scholar
Simpson, G. M. (1967). “Side-effects of phenothiazines” Brit. J. Psychiat., 113, 331.Google Scholar
Willcox, D. R. C., Gillan, R., and Hare, E. H. (1965). “Do psychiatric out-patients take their drugs” Brit. med. J., ii, 790–792.Google Scholar
Wilson, J. D., and Enoch, M. D. (1967). “Estimation of drug rejection by schizophrenic in-patients, with analysis of clinical factors” Brit. J. Psychiat., 113, 209–211.Google Scholar
McNemar, J. (1961). Analysing Qualitative Data. ed. Maxwell, A. E., 1961. Methuen.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.